CDR-Life is a privately held, biotherapeutics company leveraging its unique antibody technology, M-gager®, to target highly cancer-specific intracellular proteins presented on the major histocompatibility complex (MHC). CDR-Life is advancing a robust pipeline of novel fully cancer-directed T cell engagers in various solid tumors. The company is led by former biologics inventors, pharmaceutical drug developers and company builders, and has a strategic partnership with Boehringer Ingelheim to develop an antibody fragment-based therapeutic for geographic atrophy. Please visit www.cdr-life.com for more information or follow CDR-Life on LinkedIn and Twitter.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Switzerland
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
CDR101 - multiple myeloma, CDR404 - solid tumors
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
